Double-blind parallel placebo-controlled study to evaluate the effect of molsidomine on the endothelial dysfunction in patients with stable angina pectoris undergoing percutaneous coronary intervention: the MEDCOR Trial.
about
Double-blind parallel placebo-controlled study to evaluate the effect of molsidomine on the endothelial dysfunction in patients with stable angina pectoris undergoing percutaneous coronary intervention: the MEDCOR Trial.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Double-blind parallel placebo- ...... ntervention: the MEDCOR Trial.
@en
Double-blind parallel placebo- ...... ntervention: the MEDCOR Trial.
@nl
type
label
Double-blind parallel placebo- ...... ntervention: the MEDCOR Trial.
@en
Double-blind parallel placebo- ...... ntervention: the MEDCOR Trial.
@nl
prefLabel
Double-blind parallel placebo- ...... ntervention: the MEDCOR Trial.
@en
Double-blind parallel placebo- ...... ntervention: the MEDCOR Trial.
@nl
P2093
P2860
P1476
Double-blind parallel placebo- ...... ntervention: the MEDCOR Trial.
@en
P2093
Antoine Guédès
Arnold Herman
Bruno Pirenne
Edouard Benit
Etienne Hoffer
François Cardinal
Jacques Lalmand
Luc Janssens
Luc Missault
Patrick Chenu
P2860
P2888
P304
P356
10.1007/S12265-013-9513-9
P407
P577
2013-10-19T00:00:00Z